Summary
Under Investigation
Symptoms
Under Investigation
Diagnostic Criteria
None. (Aggarwal et al, 2015)
Study Classification Criteria
Under Investigation
Diagnostic Tests
Under Investigation
Organized Autoimmunity
(Alternative Autoimmune Disease Classification: FIEM, MIEM or BIEM, or FEM, MEM or BEM)
sex predominance (is an autoimmune disease primarily found in genetic Females, Males, or equally in Both?)
Under Investigation
Inherited and acquired gene variations that cause increased susceptibility
Human Leukocyte Antigen (HLA) Associations
Under Investigation
Other Gene Variations (mutations)
Under Investigation
Gene Triggering Environmental Exposures
Infections
Under Investigation
Toxins
Under Investigation
Stress
Needs to be assessed for each patient
Multiple interactive and destructive immune system pathologies
Under Investigation
Tissue-Type or Cell-Type Attacked
Under Investigation
Treatment(s)
Under Investigation
Managing Specialist(s)
Under Investigation
Research Authors
Under Investigation
Research Institutions
Under Investigation
Average Time from Symptom Onset to Diagnosis
Last Updated
May 15, 2023
References
Aggarwal, R., Ringold, S., Khanna, D., Neogi, T., Johnson, S.R., Miller, A., Brunner, H.I., Ogawa, R., Felson, D., Ogdie, A., Aletaha, D. and Feldman, B.M. (2015), Distinctions Between Diagnostic and Classification Criteria?. Arthritis Care & Research, 67: 891-897. https://doi.org/10.1002/acr.22583